mRNA-based anti-COVID-19 vaccines induced higher B cells and IgG levels than whole virus-based: A pilot study on Egyptian individuals
BackgroundB cells are critical components of vaccine-induced humoral immunity. However, circulating total B-cell measurements do not by themselves establish antigen specificity, memory differentiation, neutralizing activity, or protection. Aim: This exploratory observational study compared circulating CD19+ B-cell numbers and anti-SARS-CoV-2 spike receptor-binding domain (RBD) binding antibody levels according to COVID-19 vaccine platform and time since vaccination.MethodsSixty-one participants were included: 52 vaccinated participants and 9 non-vaccinated participants. Vaccinated participants had received Pfizer (BNT162b2), ChAdOx1 nCoV-19, or inactivated-virus vaccines (Sinopharm or Sinovac). Peripheral blood mononuclear cells were analyzed by flow cytometry using CD19 to quantify total circulating B cells, while anti-SARS-CoV-2 spike-RBD binding antibodies were measured using the Elecsys Anti-SARS-CoV-2 S assay.ResultsTotal CD19+ B-cell percentages and absolute numbers were not significantly different between the vaccinated platform groups and the non-vaccinated controls. Anti-SARS-CoV-2 spike-RBD binding antibody levels were significantly higher in vaccinated participants than in controls. The relationship between circulating CD19+ B-cell frequency and antibody concentration was weak.ConclusionThese exploratory findings suggest persistent humoral immune responses after COVID-19 vaccination but do not establish superiority of one vaccine platform. Because the study was limited by sample size, heterogeneous. vaccination histories, incomplete objective ascertainment of previous SARS-CoV-2 infection, and use of a binding-antibody assay rather than a functional neutralization assay, the findings should be interpreted as preliminary and require confirmation in larger, adequately powered studies.
Authors
- EL-Hassan M. Mokhamer (ORCID: https://orcid.org/0000-0003-2257-3929)
- Noura E. Sanoh
- Kadry Abd-El kader Moktar El-bakry
- Mohamed Labib Salem (ORCID: https://orcid.org/0000-0002-9580-4399)
- Sohaila Mohamed Khalil (ORCID: https://orcid.org/0009-0005-2016-2730)
- Walaa G. Ahmed (ORCID: https://orcid.org/0000-0001-6042-5244)
Institutions
- Damietta University (EG)
- Damanhour University (EG)
- Tanta University (EG)
- Tanta University Hospital (EG)
Publication Details
- Journal
- Human Antibodies
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1177/10932607261506645
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Academy of Scientific Research and Technology